Hematology and Oncology Felow
Cleveland Clinic
Cleveland, Ohio, United States
Jasmin Hundal, M.D., M.S., M.P.H. is a hematology-oncology fellow at Cleveland Clinic with a background in clinical research, lifestyle medicine, and cancer survivorship. She earned her Master of Public Health from the University of Connecticut and a Master of Science in Biotechnology from Johns Hopkins University. Dr. Hundal completed her medical degree at Ross University School of Medicine, where she was consistently recognized on the Dean’s List. During her fellowship in general internal medicine at the University of Connecticut, Dr. Hundal led the Lifestyle Medicine Track, developing educational initiatives focused on integrating preventive care and wellness into clinical practice. She currently serves as the Trainee Liaison for Oncology Member Interest Group with the American College of Lifestyle Medicine and previously held the role of Vice President of Education on the organization's Trainee Executive Board. Her clinical training includes internal medicine residency and general internal medicine fellowship at the University of Connecticut, followed by her current focus in hematology-oncology. Throughout her training, Dr. Hundal has taken on leadership roles in research and education, contributing to mentorship programs and medical student teaching. Dr. Hundal’s research focuses on the role of lifestyle factors and obesity in cancer care, with a particular interest in breast cancer. She has presented her work at national conferences and collaborated on publications addressing cancer outcomes and survivorship. She values medical education and health equity, having developed educational materials and workshops to improve care delivery and address disparities. Dr. Hundal enjoys connecting with patients and working as part of a team to improve outcomes. Outside of work, she finds balance through hiking, exploring new cultures, and participating in community health initiatives.
Disclosure information not submitted.
Applying Lifestyle Medicine to Enhance Cancer Survivorship and Patient Well-Being
Monday, November 17, 2025
3:30 PM – 4:30 PM CT